^
Association details:
Biomarker:No biomarker
Cancer:Hairy Cell Leukemia
Drug:Brukinsa (zanubrutinib) (BTK inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
11/03/2023
Excerpt:
Hairy Cell Leukemia: Other Recommended Regimens...Zanubrutinib…